Redmile Group, LLC 13D and 13G filings for Repare Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 1,942,555 4.600% | -206,193 (-9.60%) | Filing |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,148,748 5.100% | -535,648 (-19.95%) | Filing |
| 2023-02-14 4:29 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,684,396 6.400% | -105,100 (-3.77%) | Filing |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group, LLC | 2,789,496 6.700% | 141,800 (+5.36%) | Filing |